Roivant Sciences Ltd. ($ROIV)
Filing Information
| Accession Number | 0001635088-26-000019 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 24, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
9,000,000
Total Value
$93,589,460.40
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President and Vant Chair | Common Shares | โ | Feb 19, 2026 | Exercise/Conversion | 1,400,000 | $3.85 | $5,390,000.00 | 15,136,547 | Direct | โ | View Details | |
President and Vant Chair | Common Shares | โ | Feb 19, 2026 | Sale | 1,400,000 | $27.42 | $38,388,000.00 | 13,736,547 | Direct | โ | View Details | |
President and Vant Chair | Common Shares | โ | Feb 20, 2026 | Exercise/Conversion | 1,012,610 | $3.85 | $3,898,548.50 | 14,749,157 | Direct | โ | View Details | |
President and Vant Chair | Common Shares | โ | Feb 20, 2026 | Sale | 1,012,610 | $27.15 | $27,492,361.50 | 13,736,547 | Direct | โ | View Details | |
President and Vant Chair | Common Shares | โ | Feb 23, 2026 | Exercise/Conversion | 587,390 | $3.85 | $2,261,451.50 | 14,323,937 | Direct | โ | View Details | |
President and Vant Chair | Common Shares | โ | Feb 23, 2026 | Sale | 587,390 | $27.51 | $16,159,098.90 | 13,736,547 | Direct | โ | View Details | |
President and Vant Chair | Stock Option (Right to Buy) | Derivative | Feb 19, 2026 | Exercise/Conversion | 1,400,000 | $0.00 | $0.00 | 4,626,184 | Direct | โ | View Details | |
President and Vant Chair | Stock Option (Right to Buy) | Derivative | Feb 20, 2026 | Exercise/Conversion | 1,012,610 | $0.00 | $0.00 | 3,613,574 | Direct | โ | View Details | |
President and Vant Chair | Stock Option (Right to Buy) | Derivative | Feb 23, 2026 | Exercise/Conversion | 587,390 | $0.00 | $0.00 | 3,026,184 | Direct | โ | View Details |